Melinta Therapeutics to Present at Upcoming Investor Conferences

World News: . []

NEW HAVEN, Conn., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Dan Wechsler, President and CEO of Melinta, will present at the following upcoming investor conferences:

Live and archived webcasts of the presentations will also be accessible from Melinta’s Investor Relations website at .

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Tuesday 25th September 2018

Published: .

Search for other references to "melinta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us